Related Experiment Videos
Growth-related proteinases in cultured human tumour cells
Abstract:
The proliferation of normal cells, and of early-passage cells from tumours, is inhibited as a consequence of inhibition of a cell-surface proteinase activity. In contrast, established tumour cell lines are usually resistant to these effects. It has previously been suggested that the change from sensitivity to resistance may be a consequence of tumour progression, but experiments with an additional three human tumour cell cultures show that this change is not inevitable.
Insights
Inhibiting cell-surface proteinase activity stops normal and early-stage tumor cell growth. However, established tumor cells are resistant, and this resistance is not always a result of tumor progression.
Area of Science:
- Cell biology
- Biochemistry
- Cancer research
Background:
- Cell-surface proteinase activity plays a role in normal and cancerous cell proliferation.
- Established tumor cell lines often exhibit resistance to inhibition of this activity, suggesting a link to tumor progression.
Purpose of the Study:
- To investigate the relationship between cell-surface proteinase inhibition and tumor cell line resistance.
- To determine if the transition from sensitivity to resistance is an inevitable outcome of tumor progression.
Main Methods:
- Utilized three additional human tumor cell cultures for experimental analysis.
- Assessed the effects of inhibiting cell-surface proteinase activity on cell proliferation.
Main Results:
- Normal cells and early-passage tumor cells showed inhibited proliferation upon proteinase activity inhibition.
- Established tumor cell lines demonstrated resistance to these inhibitory effects.
- Experiments indicated that the development of resistance is not an inevitable consequence of tumor progression in all cases.
Conclusions:
- Cell-surface proteinase activity is a critical regulator of normal and early-stage tumor cell proliferation.
- Tumor cell resistance to proteinase inhibition is a complex phenomenon not solely dictated by tumor progression.
- Further research is warranted to understand the mechanisms underlying acquired resistance in established tumor cell lines.